Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002042145 | SCV002109405 | uncertain significance | Hypogonadotropic hypogonadism 2 with or without anosmia; Pfeiffer syndrome | 2021-08-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FGFR1-related conditions. This variant is present in population databases (rs376921992, ExAC 0.001%). This sequence change replaces methionine with valine at codon 390 of the FGFR1 protein (p.Met390Val). The methionine residue is highly conserved and there is a small physicochemical difference between methionine and valine. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV003120726 | SCV003799175 | uncertain significance | not provided | 2022-11-18 | criteria provided, single submitter | clinical testing | PM2 |
Prevention |
RCV004536367 | SCV004120980 | uncertain significance | FGFR1-related disorder | 2023-01-23 | criteria provided, single submitter | clinical testing | The FGFR1 c.1168A>G variant is predicted to result in the amino acid substitution p.Met390Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-38277167-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |